Peter Kaiser serves as Executive at OCULAR THERAPEUTIX, INC, where they oversee executive responsibilities. Since joining the company, Peter Kaiser has executed 4 insider transactions totaling $202.1K, demonstrating a bearish approach to their equity position. Their most recent transaction on Feb 23, 2026 involved selling 2,810 shares valued at $23.3K.
Peter Kaiser currently holds 269,108 shares of OCULAR THERAPEUTIX, INC (OCUL), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Peter Kaiser has been a net seller of OCUL stock. They have purchased $0 and sold $202.1K worth of shares.
Peter Kaiser's most recent insider trade was on Feb 23, 2026, when they sold 2,810 shares at $8.28 per share.
Get notified when new Form 4 filings are submitted
| $12.02 |
| Discretionary |
| Oct 2, 2025 | OCUL | $106.5K | Sale | 9,653 | $11.03 | Discretionary |
| Aug 25, 2025 | OCUL | $36.3K | Sale | 3,011 | $12.04 | Discretionary |